MiR-135a suppresses calcification in senescent VSMCs by regulating KLF4/STAT3 pathway

Current Vascular Pharmacology

Volumn 14, Issue 2, 2016, Pages 211-218

  Lin, Lin ^a   He, Yue ^a   Xi, Bei Li ^a   Zheng, Hong Chao ^a   Chen, Qian ^a   Li, Jun ^a   Hu, Ying ^a   Ye, Ming Hao ^a   Chen, Ping ^a   Qu, Yi ^a  

^a INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

Author keywords

Calcification; KLF4; MiR 135a; STAT3; Vascular smooth muscle cell

Indexed keywords

ALKALINE PHOSPHATASE; CALCIUM; KRUPPEL LIKE FACTOR 4; LIPOFECTAMINE; MICRORNA; MICRORNA 135A; OSTEOCALCIN; STAT3 PROTEIN; UNCLASSIFIED DRUG; KRUPPEL LIKE FACTOR; MIRN135 MICRORNA, RAT; STAT3 PROTEIN, RAT;

3' UNTRANSLATED REGION; ANIMAL CELL; ARTICLE; CALCIFICATION; CELL COUNT; CELL ISOLATION; CELL PROLIFERATION; CELLULAR PARAMETERS; CONTROLLED STUDY; ENZYME ACTIVITY; LUCIFERASE ASSAY; MALE; MICROARRAY ANALYSIS; NONHUMAN; POPULATION DOUBLING TIME; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION; VASCULAR SMOOTH MUSCLE CELL; WESTERN BLOTTING; ANIMAL; BIOSYNTHESIS; BLOOD VESSEL CALCIFICATION; CELL AGING; CELL CULTURE; METABOLISM; PATHOLOGY; PHYSIOLOGY; SMOOTH MUSCLE CELL; SPRAGUE DAWLEY RAT; VASCULAR SMOOTH MUSCLE;

ANIMALS; CELL AGING; CELLS, CULTURED; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MALE; MICRORNAS; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; VASCULAR CALCIFICATION;

EID: 84958972389     PISSN: 15701611     EISSN: 18756212     Source Type: Journal    
DOI: 10.2174/1570161113666150722151817     Document Type: Article

References (45)

1. Goettsch C, Rauner M, Pacyna N, Hempel U, Bornstein SR, Hofbauer LC. miR-125b regulates calcification of vascular smooth muscle cells. Am J Pathol 2011; 179(4): 1594-600.
2. Mathew S, Tustison KS, Sugatani T, Chaudhary LR, Rifas L, Hruska KA. The mechanism of phosphorus as a cardiovascular risk factor in CKD. J Am Soc Nephrol 2008; 19(6): 1092-105.
3. Reynolds JL, Joannides AJ, Skepper JN, et al. Human vascular smooth muscle cells undergo vesicle-mediated calcification in response to changes in extracellular calcium and phosphate concentrations: a potential mechanism for accelerated vascular calcification in ESRD. J Am Soc Nephrol 2004; 15(11): 2857-67.
4. Pan ZW, Lu YJ, Yang BF. MicroRNAs: a novel class of potential therapeutic targets for cardiovascular diseases. Acta Pharmacol Sin 2010; 31(1): 1-9.
5. Urbich C, Kuehbacher A, Dimmeler S. Role of microRNAs in vascular diseases, inflammation, and angiogenesis. Cardiovasc Res 2008; 79(4): 581-8.
6. Fichtlscherer S, De Rosa S, Fox H, et al. Circulating microRNAs in patients with coronary artery disease. Circ Res 2010; 107(5): 677-84.
7. Zampetaki A, Kiechl S, Drozdov I, et al. Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes. Circ Res 2010; 107(6): 810-7.
8. Wen P, Cao H, Fang L, et al. miR-125b/Ets1 axis regulates transdifferentiation and calcification of vascular smooth muscle cells in a high-phosphate environment. Exp Cell Res 2014; 322(2): 302-12.
9. Ohnaka M, Marui A, Yamahara K, et al. Effect of microRNA-145 to prevent vein graft disease in rabbits by regulation of smooth muscle cell phenotype. J Thorac Cardiovasc Surg 2014; 148(2): 676-82.
10. Sun SG, Zheng B, Han M, et al. miR-146a and Kruppel-like factor 4 form a feedback loop to participate in vascular smooth muscle cell proliferation. EMBO Rep 2011; 12(1): 56-62.
11. Nagel R, le Sage C, Diosdado B, et al. Regulation of the adenomatous polyposis coli gene by the miR-135 family in colorectal cancer. Cancer Res 2008; 68(14): 5795-802.
12. Zhou W, Li X, Liu F, et al. MiR-135a promotes growth and invasion of colorectal cancer via metastasis suppressor 1 in vitro. Acta Biochim Biophys Sin (Shanghai) 2012; 44(10): 838-46.
13. Tang W, Jiang Y, Mu X, Xu L, Cheng W, Wang X. MiR-135a functions as a tumor suppressor in epithelial ovarian cancer and regulates HOXA10 expression. Cell Signal 2014; 26(7): 1420-6.
14. Liu S, Guo W, Shi J, et al. MicroRNA-135a contributes to the development of portal vein tumor thrombus by promoting metastasis in hepatocellular carcinoma. J Hepatol 2012; 56(2): 389-96.
15. Lee HY, Ahn JB, Rha SY, et al. High KLF4 level in normal tissue predicts poor survival in colorectal cancer patients. World J Surg Oncol 2014; 12: 232.
16. Yoshida T, Hayashi M. Role of Kruppel-like factor 4 and its binding proteins in vascular disease. J Atheroscler Thromb 2014; 21(5): 402-13.
17. Turner EC, Huang CL, Govindarajan K, Caplice NM. Identification of a Klf4-dependent upstream repressor region mediating transcriptional regulation of the myocardin gene in human smooth muscle cells. Biochim Biophys Acta 2013; 1829(11): 1191-201.
18. Fukuyo S, Yamaoka K, Sonomoto K, et al. IL-6-accelerated calcification by induction of ROR2 in human adipose tissue-derived mesenchymal stem cells is STAT3 dependent. Rheumatology (Oxford) 2014; 53(7): 1282-90.
19. Villa-Bellosta R, Sorribas V. Phosphonoformic acid prevents vascular smooth muscle cell calcification by inhibiting calciumphosphate deposition. Arterioscler Thromb Vasc Biol 2009; 29(5): 761-6.
20. Verberckmoes SC, Persy V, Behets GJ, et al. Uremia-related vascular calcification: More than apatite deposition. Kidney Int 2007; 71(4): 298-303.
21. Martín-Pardillos A, Sosa C, Sorribas V. Arsenic increases Pimediated vascular calcification and induces premature senescence in vascular smooth muscle cells. Toxicol Sci 2013; 131(2): 641-53.
22. Roosens B, Bala G, Droogmans S, et al. Occurrence of cardiovascular calcifications in normal, aging rats. Exp Gerontol 2012; 47(8): 614-9.
23. Gui T, Zhou G, Sun Y, et al. MicroRNAs that target Ca(2+) transporters are involved in vascular smooth muscle cell calcification. Lab Invest 2012; 92(9): 1250-9.
24. Rangrez AY, M'Baya-Moutoula E, Metzinger-Le Meuth V, et al. Inorganic phosphate accelerates the migration of vascular smooth muscle cells: evidence for the involvement of miR-223. PLoS One 2012; 7(10): e47807.
25. Mackenzie NC, Staines KA, Zhu D, Genever P, Macrae VE. miRNA-221 and miRNA-222 synergistically function to promote vascular calcification. Cell Biochem Funct 2014; 32(2): 209-16.
26. Liao XB, Zhang ZY, Yuan K, et al. MiR-133a modulates osteogenic differentiation of vascular smooth muscle cells. Endocrinology 2013; 154(9): 3344-52.
27. Wen P, Cao H, Fang L, et al. miR-125b/Ets1 axis regulates transdifferentiation and calcification of vascular smooth muscle cells in a high-phosphate environment. Exp Cell Res 2014; 322(2): 302-12.
28. Earle JS, Luthra R, Romans A, et al. Association of microRNA expression with microsatellite instability status in colorectal adenocarcinoma. J Mol Diagn 2010; 12(4): 433-40.
29. Greco S, De Simone M, Colussi C, et al. Common micro-RNA signature in skeletal muscle damage and regeneration induced by Duchenne muscular dystrophy and acute ischemia. FASEB J 2009; 23(10): 3335-46.
30. Saunders LR, Sharma AD, Tawney J, et al. miRNAs regulate SIRT1 expression during mouse embryonic stem cell differentiation and in adult mouse tissues. Aging (Albany NY) 2010; 2(7): 415-31.
31. Nissen SE, Nicholls SJ, Sipahi I, et al. Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial. JAMA 2006; 295(13): 1556-65.
32. Kizu A, Shioi A, Jono S, Koyama H, Okuno Y, Nishizawa Y. Statins inhibit in vitro calcification of human vascular smooth muscle cells induced by inflammatory mediators. J Cell Biochem 2004; 93(5): 1011-9.
33. Son BK, Kozaki K, Iijima K, et al. Gas6/Axl-PI3K/Akt pathway plays a central role in the effect of statins on inorganic phosphateinduced calcification of vascular smooth muscle cells. Eur J Pharmacol 2007; 556(1-3): 1-8.
34. Li J, Chen H, Ren J, et al. Effects of statin on circulating microRNAome and predicted function regulatory network in patients with unstable angina. BMC Med Genomics 2015; 8: 12.
35. Cerda A, Fajardo CM, Basso RG, Hirata MH, Hirata RD. Role of microRNAs 221/222 on statin induced nitric oxide release in human endothelial cells. Arq Bras Cardiol 2015; 104(3): 195-201.
36. Yoshida T, Yamashita M, Hayashi M. Kruppel-like factor 4 contributes to high phosphate-induced phenotypic switching of vascular smooth muscle cells into osteogenic cells. J Biol Chem 2012; 287(31): 25706-14.
37. Chen Z, Couble ML, Mouterfi N, Magloire H, Chen Z, Bleicher F. Spatial and temporal expression of KLF4 and KLF5 during murine tooth development. Arch Oral Biol 2009; 54(5): 403-11.
38. Zheng X, Li A, Zhao L, et al. Key role of microRNA-15a in the KLF4 suppressions of proliferation and angiogenesis in endothelial and vascular smooth muscle cells. Biochem Biophys Res Commun 2013; 437(4): 625-31.
39. Liu Y, Zheng B, Zhang XH, Nie CJ, Li YH, Wen JK. Localization and function of KLF4 in cytoplasm of vascular smooth muscle cell. Biochem Biophys Res Commun 2013; 436(2): 162-8.
40. Atkins GB, Jain MK. Role of Kruppel-like transcription factors in endothelial biology. Circ Res 2007; 100(12): 1686-95.
41. Mun GI, Boo YC. A regulatory role of Kruppel-like factor 4 in endothelial argininosuccinate synthetase 1 expression in response to laminar shear stress. Biochem Biophys Res Commun 2012; 420(2): 450-5.
42. Zhou G, Hamik A, Nayak L, et al. Endothelial Kruppel-like factor 4 protects against atherothrombosis in mice. J Clin Invest 2012; 122(12): 4727-31.
43. Qin S, Zou Y, Zhang CL. Cross-talk between KLF4 and STAT3 regulates axon regeneration. Nat Commun 2013; 4: 2633.
44. Palit S, Kendrick J. Vascular calcification in chronic kidney disease: role of disordered mineral metabolism. Curr Pharm Des 2014; 20(37): 5829-33.
45. Taïbi F, Metzinger-Le Meuth V, M'Baya-Moutoula E, et al. Possible involvement of microRNAs in vascular damage in experimental chronic kidney disease. Biochim Biophys Acta 2014; 1842(1): 88-98.